Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 50 | 0 | 7 | 0 | €752.70 | €786.51 | 4.491% |
| Biogen Inc. | 50 | 1 | 7 | 0 | €203.30 | €293.22 | 44.232% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 7 | 0 | €409.10 | €409.07 | -0.008% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 3 | 0 | €896.00 | €958.32 | 6.955% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €115.00 | €124.92 | 8.628% |
| Pfizer Inc. | 27 | 4 | 1 | 0 | €26.04 | €40.66 | 56.172% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €277.95 | €296.16 | 6.550% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €156.42 | €200.06 | 27.898% |
| AbbVie Inc. | 22 | 0 | 2 | 0 | €144.38 | €175.11 | 21.285% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €93.96 | €116.71 | 24.216% |
| Incyte Corp. | 12 | 2 | 2 | 0 | €52.92 | €78.42 | 48.190% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €16.25 | €15.58 | -4.080% |